Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissectionStéphanie Debette, Marie‐Germaine Bousser, Andrew M. Southerland et al.|The Lancet Neurology|2015Cited by 464
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trialḰazunori Toyoda, Naoko Kumagai, Shinichiro Uchiyama et al.|The Lancet Neurology|2019Cited by 216
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)J. Donald Easton, David Paulon, Maria Aunes et al.|Circulation|2017Cited by 33
Aspirin for Stroke Prevention in Elderly Patients With Vascular Risk FactorsShinichiro Uchiyama, Yasuo Ikeda, Naoki Ishizuka et al.|Stroke|2016Cited by 30
Seasonal Variations in Neurological Severity and Outcomes of Ischemic Stroke ― 5-Year Single-Center Observational Study ―Ḱazunori Toyoda, Kazuo Minematsu, Masatoshi Koga et al.|Circulation Journal|2018Cited by 30